(Q51602860)
Statements
Effects of a new oral hypoglycaemic agent, repaglinide, on metabolic control in sulphonylurea-treated patients with NIDDM. (English)
1 reference
L Nijst
1 reference
J P Sels
1 reference
P P Menheere
1 reference
P G Müller
1 reference
A C Kruseman
1 reference
1 January 1993
1 reference
45
1 reference
2
1 reference
113-116
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference